96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
PEPTIDIC INHIBITOR OF SIGNAL TRANSMISSION FROM G-ALPHA-S TO G-ALPHA-I-COUPLED RECEPTOR CASCADES
#3002Amphiphilic peptides for treatment of keratitis
#3003METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS
#3004Compositions and methods for analyzing histidine phosphorylation
#3005Peptides for the Treatment of Hearing
#3006POLYPEPTIDES IN PREPARATION OF DRUGS FOR TREATMENT OR PREVENTION OF RHEUMATOID ARTHRITIS
#3007Peptides and methods of using same
#3008ANTICANCER FUSION PROTEIN
#3009NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF
#3010Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#3011Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications
#3012High purity lipopeptides
#3013Modified epitopes for boosting CD4+ T-cell responses
#3014Compositions and methods for treating influenza
#3015Ligands to radiation-induced molecules
#3016SKIN OR HAIR BINDING PEPTIDES
#3017Beta-hairpin peptidomimetics having CXCR4 antagonizing activity
#3018Cell-penetrating peptides
#3019Peptide compounds for inhibition of platelet aggregation
#3020Activation of bioluminescence by structural complementation
#3021Therapeutic approach for polyglutamine degeneration
#3022Erythrocyte-binding therapeutics
#3023Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
#3024ALPHA-CONOTOXIN PEPTIDES
#3025Functional lipid constructs
#3026Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein
#3027N-ACYLPEPTIDE DERIVATIVES AND THEIR USES
#3028Targeted antimicrobial moieties
#3029Real-time analysis for cross-linked peptides
#3030Treatments for gastrointestinal disorders
#3031TCL1 peptides for immunotherapy
#3032SYNTHETIC PEPTIDES AND RANDOM COPOLYMERS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
#3033Activation of bioluminescence by structural complementation
#3034CELL KILLING FUSION PEPTIDE EXHIBITING TUMOR CELL-SPECIFIC NECROSIS INDUCTION AND TUMOR REGRESSION
#3035Treatments for gastrointestinal disorders
#3036Kinase inhibitors and uses thereof
#3037Cell-penetrating peptides having a central hydrophobic domain
#3038proteins, nucleic acids, and methods of their use
#3039Nanoparticle-peptide compositions
#3040Peptides from chaperonin 60.1
#3041Targeting the EGFR-SGLT1 interaction for cancer therapy
#3042Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof
#3043MODULATION OF GHRELIN LEVELS AND GHRELIN/UNACYLATED GHRELIN RATIO USING UNACYLATED GHRELIN
#3044Anti-inflammatory peptides and use thereof
#3045ACTH prophylactic treatment of renal disorders
#3046Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#3047INTESTINAL PEPTIDE TARGETING LIGANDS
#3048Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#3049Methods and Compositions for the Treatment of Gastrointestinal Disorders
#3050PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES
#3051Angiogenic active lytic peptides
#3052Antibiotic peptide and preparation method therefor and application therefor
#3053Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#3054Development of novel macromolecule transduction domain with improved cell permeability and method for using same
#3055SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF
#3056INOTROPIC COMPOUNDS
#3057Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
#3058Use of fibromodulin and lumican for increasing muscle mass
#3059Treatments for gastrointestinal disorders
#3060Uses of peptides to treat brain injury and disease
#3061METHODS AND COMPOSITIONS RELATED TO INHIBITION OF VIRAL ENTRY
#3062METHODS, PEPTIDES AND BIOSENSORS USEFUL FOR DETECTING A BROAD SPECTRUM OF BACTERIA
#3063ANTAGONISTS OF MUC1
#3064Method of treating endometriosis
#3065THERAPEUTIC PEPTIDES
#3066Self-assembling peptides incorporating modifications and methods of use thereof
#3067Cyclin A1-targeted T-cell immunotherapy for cancer
#3068Peptides for Treating Alzheimers's Disease and Related Conditions
#3069Peptides for Progressive Treating Multi-Focal Leukoencephalopathy and Related Conditions
#3070Peptides for the Treatment of Multiple Sclerosis and Related Diseases
#3071Fragments of p97 and uses thereof
#3072Peptide preparations and peptides with antitumour activity
#3073Compositions and methods for regulating glucose metabolism
#3074Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#3075Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein
#3076Antimicrobial peptides
#3077Beta-lactoglobulin peptides for treating cow's milk protein allergy
#3078ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF
#3079Modified antibiotic peptides having variable systemic release
#3080WNT family-derived peptides and use thereof
#3081Methods for treating kidney disease with fragments of ApoB-100
#3082Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#3083HLA-DR7 HY epitope and method for treating leukaemia
#3084Pro-coagulant compounds and methods of use thereof
#3085Antisense antiviral compound and method for treating influenza viral infection
#3086Anti-microbial peptides and methods of use thereof
#3087Multiplexed detection with isotope-coded reporters
#3088Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTION
#3089Products useful for the treatment of malignant neoplasms of the human nervous system
#3090PAT-LM1 epitopes and methods for using same
#3091METHOD TO SCREEN FOR SELECTIVE PEPTIDES THAT INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN
#3092Antagonist peptide of the bond between CD47 and a protein belonging to the thrombospondin family
#3093Methods and Compositions for the Treatment of Gastrointestinal Disorders
#3094MITOCHONDRIAL-DERIVED PEPTIDE MOTS3 REGULATES METABOLISM AND CELL SURVIVAL
#3095Anti-bacterial polypeptides and pathogen specific synthetic antibodies
#3096ANTIVIRAL PEPTIDES EFFECTIVE AGAINST HEPATITIS C VIRUS
#3097NOVEL A4B7 PEPTIDE ANTAGONISTS
#3098Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#3099SERUM ALBUMIN BINDING PEPTIDES FOR TUMOR TARGETING
#3100COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS
#3101Template-fixed peptidomimetics as inhibitors of FPR1
#3102Agonists of guanylate cyclase and their uses
#3103Compositions useful for the treatment of gastrointestinal disorders
#3104Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
#3105Self-assembling peptide and peptide gel with high strength
#3106KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
#3107Inhibitors of mitochondrial fission and methods of use thereof
#3108Compounds for control of appetite
#3109NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS
#3110IgG-binding peptide and method for detecting and purifying IgG using same
#3111Aqueous liquid composition
#3112Immunogenic epitopes for immunotherapy
#3113Immunologically active polypeptide
#3114Stabilized Variant MAML Peptides and Uses Thereof
#3115EXTRACT AND PEPTIDES DERIVED FROM ORYZA SATIVA JAPONICA GROUP AND USES THEREOF
#3116PEPTOID NEUTRALIZING AGENTS
#3117PEPTOID NEUTRALIZING AGENTS
#3118Anti-angiogenic molecules, nanostructures and uses thereof
#3119Treatments for Gastrointestinal Disorders
#3120Compositions for treating glioma
#3121Compositions and methods for augmenting permeability barriers
#3122Modulation of structured polypeptide specificity
#3123Peptide-bound gold metal nano-clusters as cancer cell killing agents
#3124Lytic domain fusion constructs and methods of making and using same
#3125RECOMBINANT HUMAN NAGLU PROTEIN AND USES THEREOF
#3126ESTROGEN-RECEPTOR BASED LIGAND SYSTEM FOR REGULATING PROTEIN STABILITY
#3127Methods and compositions comprising a C-terminal Bax peptide
#3128Light-inducible system for regulating protein stability
#3129Modulation of structured polypeptide specificity
#3130Polypeptides and their use
#3131Heterologous intron within a signal peptide
#3132Quantification of vaccine compositions
#3133Combination adjuvant formulation
#3134Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
#3135Methods of using ERBB2 conjugate peptides
#3136Arenavirus inhibiting peptides and uses therefor
#3137Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
#3138METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY
#3139Compositions and methods for introduction of macromolecules into cells
#3140Methods for detection of botulinum neurotoxin
#3141Peptides and related molecules that bind to TALL-1
#3142POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#3143PARATHYROID HORMONE ANALOGS, COMPOSITIONS AND USES THEREOF
#3144Peptide inhibitors of BACE1
#3145Regulation of sodium channels by PLUNC proteins
#3146Cell penetrating peptides for intracellular delivery of molecules
#3147Method for Removing Immunosuppressive Properties of HIV Envelope Glycoproteins
#3148Anti-RhoB antibodies
#3149Bovine fusion antibodies
#3150A2M FRAGMENTS AND APPLICATIONS THEREOF
#3151Peptides that selectively home to heart vasculature and related conjugates and methods
#3152Binding molecules for human factor VIII and factor VIII-like proteins
#3153Dispersion and detachment of cell aggregates
#3154Activation of sodium potassium ATPase
#3155Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
#3156Anti-microbial peptides and methods of use thereof
#3157Lymphatic zip codes in tumors and pre-malignant lesions
#3158Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response
#3159Amphiphilic peptides and hydrogel matrices thereof for bone repair
#3160Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis
#3161SMALL HUMANIN-LIKE PEPTIDES
#3162Beta-hairpin peptidomimetics as CXC4 antagonists
#3163Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#3164RNA targeting compounds and methods for making and using same
#3165T cell receptor and uses thereof
#3166Immunity to folate receptors
#3167Nuclear targeting sequences
#3168Compositions and methods for recognition of RNA using triple helical peptide nucleic acids
#3169Targeting vector-phospholipid conjugates
#3170Polypeptides for treating and/or limiting influenza infection
#3171Cancer therapy method
#3172Bioactive carbon nanotube composite functionalized with B-sheet polypeptide block copolymer, and preparation method thereof
#3173Multivalent constructs for therapeutic and diagnostic applications
#3174Cell-permeable peptide inhibitors of the JNK signal transduction pathway
#3175Immunotherapeutic Methods Using Epitopes of WT-1 and GATA-1
#3176Aquaporin-4 peptide compositions and methods of use thereof
#3177Polypeptides and use thereof
#3178AGONISTIC AUTOANTIBODIES TO THE ALPHA1-ADRENERGIC RECEPTOR AND THE BETA2-ADRENERGIC RECEPTOR IN ALZHEIMER'S AND VASCULAR DEMENTIA
#3179Synthetic peptides and peptide mimetics
#3180Influenza inhibiting compositions and methods
#3181BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#3182α4β7 peptide dimer antagonists
#3183Membrane transporter NaPi2b (SCL34A2) epitope antibodies
#3184METHOD FOR PREPARING BIVALIRUDIN
#3185Peptide linkers for polypeptide compositions and methods for using same
#3186Inhibitors of viral integrase and methods of use
#3187Template-fixed peptidomimetics with antimicrobial activity
#3188Template-fixed peptidomimetics with antimicrobial activity
#3189PEPTIDE FOR VACCINE
#3190Macromolecule transduction domains and methods for identification and uses thereof
#3191TREATMENT OF ATHEROSCLEROSIS WITH CHOLESTEROL ESTER TRANSPORT PROTEIN MIMOTOPES
#3192POLYPEPTIDE, NUCLEOTIDE SEQUENCE THEREOF, AND METHOD FOR USING THE SAME FOR PREVENTING DNA SYNTHESIS AND INHIBITING CELL PROLIFERATION
#3193Peptides that stimulate subcutaneous adipogenesis
#3194Metallothionein-derived peptide fragments
#3195Materials and Methods Related to Sodium/Potassium Adenosine Triphosphatase and SRC
#3196Treatments for Gastrointestinal Disorders
#3197Cell proliferation-promoting peptide and use thereof
#3198Retrograde transport peptide and use of same for delivery to central nervous system
#3199Peptide inhibitors of protein kinase C
#3200High affinity SUMO traps
#3201Phoenixin peptides
#3202Compositions and methods for transport across the blood brain barrier
#3203Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof
#3204Methods of Modulating Vesicular Trafficking
#3205Methods of using myelin basic protein peptide compositions
#3206Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis
#3207Self-Assembling Peptide and Peptide Gel with High Strength
#3208KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
#3209Molecular imaging of cancer cells in vivo
#3210F11 receptor (F11R) antagonists as therapeutic agents
#3211Process of preparing guanylate cyclase C agonists
#3212Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
#3213Peptides and compositions for prevention of cell adhesion and methods of using same
#3214Selectively targeted antimicrobial peptides and the use thereof
#3215Synthetic linear apelin mimetics for the treatment of heart failure
#3216Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#3217Inhibition of TREM receptor signaling with peptide variants
#3218Chemokine binding polypeptides for treating autoimmunity and inflammation
#3219Compositions and methods for modulating gamma-c-cytokine activity
#3220Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation
#3221ANTIBACTERIAL PEPTIDES
#3222Guanylylcyclase C ligands
#3223Cyclic peptide from sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
#3224Synthetic apelin mimetics for the treatment of heart failure
#3225CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS
#3226Peptides and methods using same
#3227Lipopeptide inhibitors of RAS oncoproteins
#3228Mitochondrial targeting and therapeutic use thereof
#3229Screening methods for identifying proteases inhibitors
#3230Method for transforming a bacterium belonging to the genus by natural competence
#3231EphA2 T-cell epitope agonists and uses therefore
#3232PHOSPHORYLATION OF HISTONES AND USES THEREOF
#3233Method for acquiring a heat-stable antibody-displayed phage
#3234Antimicrobial peptides and uses therefore
#3235Antimicrobial lytic peptides
#3236Methods of constructing and screening libraries of peptide structures
#3237Powerful MHC-class II peptides derived from survivin
#3238Natural IgM antibodies and inhibitors thereof
#3239Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
#3240Shortened secreted polypeptides
#3241Modification of peptides via SAr reactions of thiols with fluorinated aromatics
#3242Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof
#3243Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
#3244Polypeptide inhibitors of HSP27 kinase and uses therefor
#3245Melanocortin 1 receptor ligands and methods of use
#3246KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
#3247Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof
#3248Template-fixed peptidomimetics
#3249Stabilized bioactive peptides and methods of identification, synthesis, and use
#3250Plant-derived elastin binding protein ligands and methods of using the same
#3251Combination therapy and kit for the prevention and treatment of cystic fibrosis
#3252Methods and compositions for targeting progenitor cell lines
#3253ANTAGONIST FOR (PRO)RENIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION AND DIABETES
#3254Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
#3255Preparation of Neutralizing Antibody to Human Herpesvirus 6 Glycoprotein Q1 and Analysis Thereof
#3256Therapeutic DLL4 binding proteins
#3257sGCalphal inhibiting compositions
#3258Stem Cell Mobilization and Tissue Repair and Regeneration
#3259Template-fixed peptidomimetics with antimicrobial activity
#3260Methods for preparing purified lipopeptides
#3261NOVEL AND POWERFUL MHC-CLASS II PEPTIDES DERIVED FROM SURVIVIN
#3262Skin or hair binding peptides
#3263Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
#3264Linker peptides and polypeptides comprising same
#3265Treatments for gastrointestinal disorders
#3266Antagonists of the interleukin-1 receptor
#3267Functionalized biomaterials for tissue regeneration
#3268NOVEL GENES AND PROTEINS THAT HOME TO DEVELOPING MICROVESSELS
#3269Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
#3270T-CELL DEATH-INDUCING EPITOPES
#3271Carrier peptides for cell delivery
#3272Cross-linked peptides and proteins, methods of making same, and uses thereof
#3273Compositions of A-8R peptide
#3274Treatment of cancers with A-8R peptide
#3275ANTI-FIBROTIC PEPTIDES AND THEIR USE IN METHODS FOR TREATING DISEASES AND DISORDERS CHARACTERIZED BY FIBROSIS
#3276Anti-inflammatory antibodies and uses therefor
#3277METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSION PROTEINS
#3278Synthetic peptide that induces expression of TNF receptor 2 and use thereof
#3279Compositions for inhibiting virus entry and promoting virolysis, and methods thereof
#3280Vaccine peptide combinations
#3281Hydrogen bond surrogate macrocycles as modulators of Ras
#3282Methods of protecting against apoptosis using lipopeptides
#3283Compositions and methods for coronavirus inhibition
#3284Fusion protein
#3285TDF-related compounds and analogs thereof
#3286Tissue occluding agent comprising an IEIKIEIKIEIKI peptide
#3287Method of treating metastatic cancer
#3288Hydrophobic modified peptides and their use for liver specific targeting
#3289Compositions and methods for promoting wound healing and tissue regeneration
#3290MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective
#3291Compositions for detecting an infection by an HIV-1 virus
#3292Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)
#3293Tricalcium phosphate binding peptides and uses thereof
#3294Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same
#3295Peptidic activators of type I cGMP dependent protein kinases and uses thereof
#3296Targeting vector-phospholipid conjugates
#3297Synthetic peptides and their use
#3298Peptide aptamers against tenascin C
#3299ZONA PELLUCIDA BINDING PEPTIDES, EXPRESSION VECTORS, COMPOSITIONS, AND METHODS FOR SPECIES-SPECIFIC IMMUNOCONTRACEPTION OF ANIMALS
#3300Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders